ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1293

Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies

Evelyne Vinet1, Paul R. Fortin2, Stéphanie Roberge3, Emmanuel Bujold4 and Nils Chaillet5, 1Divisions of Rheymatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 2Infectious Diseases and Immunity Research Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada, 3Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada, 4Reproduction, mother and youth health, Centre Hospitalier de l'Université Laval (CHUL), Québec, QC, Canada, 5Département d’obstétrique et gynécologie et département de Médecine de famille et médecine d’urgence, Université de Sherbrooke, Sherbrooke, QC, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Outcome measures, pregnancy and women's health, Reproductive Health, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Pregnant SLE women are at increased risk of cesarean delivery compared to pregnant women from the general population. Yet, to date, no one has evaluated the indications for cesarean delivery in SLE pregnancies. Using the large population-based “QUAlity of care, obstetrics RISk MAnagement, and mode of delivery (QUARISMA)” cohort, we assessed indications for cesarean delivery in SLE pregnancies versus unaffected pregnancies.

Methods: The QUARISMA cohort includes 184,952 pregnancies and was established as part of a cluster-randomized, controlled trial, which aimed to evaluate the effect of a 1.5-year intervention, involving audits of indications for cesarean delivery and feedback to healthcare professionals, at 32 hospitals in Quebec (2008-2011). The intervention had a small effect on the rate of cesarean delivery (Chaillet, NEJM, 2015). As part of the trial, in-hospital data, including maternal SLE status and information on indications for cesarean delivery, were abstracted by trained professionals from the medical records.

For the present study, we individually matched 4:1 SLE pregnancies to unexposed pregnancies on maternal age, parity, body mass index (BMI), hospital of delivery, QUARISMA intervention group, and intervention period. We identified cesarean deliveries in SLE and unexposed pregnancies, and ascertained their indications. We performed multivariate analyses to estimate the risk of cesarean delivery for any indications, as well as the risk of cesarean delivery for fetal distress (e.g. cardiac distress, prematurity, intra-uterine growth restriction, stillbirth), maternal disease, and/or preeclampsia in SLE pregnancies versus controls, adjusting for BMI and multiple births.

Results: We identified 122 SLE pregnancies and 488 unexposed pregnancies. Cesarean deliveries occurred in 35/122 (29%) of SLE pregnancies versus 132/488 (27%) of unexposed pregnancies. Among the 35 SLE cesarean deliveries, indications included (but were not limited to) cardiac distress in 34%, prematurity in 29%, maternal disease in 20%, and preeclampsia in 11%. Among the 132 unexposed cesarean deliveries, 28% were due to cardiac distress, 10% to prematurity, 4% to maternal disease, and 6% to preeclampsia. In multivariate analyses, there was a trend for an increased risk of cesarean delivery for any indications in SLE versus unexposed pregnancies (OR 1.6; 95% CI 0.9,2.9). Moreover, SLE pregnancies had a substantially increased risk of cesarean delivery for fetal distress, preeclampsia, and/or maternal disease versus unexposed pregnancies (OR 2.6; 95% CI 1.2,5.3).

Conclusion: Cesarean deliveries in SLE pregnancies are more often due to fetal distress, preeclampsia, and/or maternal disease than cesarean deliveries in pregnancies from the general population.


Disclosure: E. Vinet, None; P. R. Fortin, None; S. Roberge, None; E. Bujold, None; N. Chaillet, None.

To cite this abstract in AMA style:

Vinet E, Fortin PR, Roberge S, Bujold E, Chaillet N. Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/indications-for-cesarean-delivery-in-systemic-lupus-erythematosus-pregnancies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/indications-for-cesarean-delivery-in-systemic-lupus-erythematosus-pregnancies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology